Elke Markert
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 4
- Cancer, Lipids, and Metabolism 4
- Cancer-related molecular mechanisms research 3
- Oncology top 5%
- Cancer-related Molecular Pathways 6
- Molecular Biology top 5%
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 5
- Biotechnology top 5%
- Biochemistry top 5%
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- Arnold J. LevineAlexei VázquezGerry MelinoAmanda FormosaEleonora CandiZoltán N. OltvaiHideaki MizunoScott W. Lowe
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Oncogene (4 papers)Cell Death and Disease (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Elke Markert
33 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 1.3k
- Oncology 881
- Molecular Biology 2.1k
- Biotechnology 151
- Biochemistry 84
Countries citing papers authored by Elke Markert
This map shows the geographic impact of Elke Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Markert more than expected).
Fields of papers citing papers by Elke Markert
This network shows the impact of papers produced by Elke Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Markert. The network helps show where Elke Markert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elke Markert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 19 | |
| 3 | 2021 | 10 | |
| 4 | 2019 | 94 | |
| 5 | 2018 | 22 | |
| 6 | 2018 | 17 | |
| 7 | 2017 | 54 | |
| 8 | 2015 | 37 | |
| 9 | 2015 | 25 | |
| 10 | 2015 | 51 | |
| 11 | 2015 | 63 | |
| 12 | Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signalingbreakdown → | 2014 | 362 |
| 13 | 2014 | 49 | |
| 14 | 2013 | 207 | |
| 15 | 2013 | 104 | |
| 16 | 2013 | 262 | |
| 17 | 2012 | 154 | |
| 18 | 2011 | 68 | |
| 19 | 2010 | 2 | |
| 20 | 2009 | 217 |
About Elke Markert
Elke Markert is a scholar working on Cancer Research, Molecular Biology, Oncology, Ophthalmology and Cell Biology, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), RNA modifications and cancer (7 papers), Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (5 papers), Prostate Cancer Treatment and Research (5 papers), MicroRNA in disease regulation (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (881 citations), Molecular Biology (2.1k citations), Biotechnology (151 citations) and Biochemistry (84 citations). Elke Markert has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Arnold J. Levine, Alexei Vázquez, Gerry Melino, Amanda Formosa, Eleonora Candi, Zoltán N. Oltvai, Hideaki Mizuno, Scott W. Lowe, В. А. Белый and Wanglai Hu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Oncogene, Cell Death and Disease, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.